Insulet (PODD) Operating Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 950.00 |
| Dec 31, 2025 | 2,163.00 |
| Sep 30, 2025 | 649.00 |
| Jun 30, 2025 | 650.00 |
| Mar 31, 2025 | 1,182.00 |
| Dec 31, 2024 | 965.00 |
| Sep 30, 2024 | 735.00 |
| Jun 30, 2024 | 687.00 |
| Mar 31, 2024 | 831.00 |
| Dec 31, 2023 | 1,105.00 |
| Sep 30, 2023 | 812.00 |
| Jun 30, 2023 | 436.00 |
| Dec 31, 2022 | 694.00 |
| Sep 30, 2022 | -83.00 |
| Jun 30, 2022 | -586.00 |
| Mar 31, 2022 | 2,056.00 |
| Dec 31, 2021 | 1,919.00 |
| Sep 30, 2021 | 968.00 |
| Jun 30, 2021 | 1,159.00 |
| Mar 31, 2021 | 1,601.00 |
| Dec 31, 2020 | 1,209.00 |
| Sep 30, 2020 | 3,089.00 |
| Jun 30, 2020 | 3,537.00 |
| Mar 31, 2020 | 1,888.00 |
| Dec 31, 2019 | 703.00 |
| Sep 30, 2019 | 1,268.00 |
| Jun 30, 2019 | 1,162.00 |
| Mar 31, 2019 | 730.00 |
| Dec 31, 2018 | 954.00 |
| Sep 30, 2018 | 3,288.00 |
| Jun 30, 2018 | 1,317.00 |
| Dec 31, 2017 | 994.00 |
| Sep 30, 2017 | 1,715.00 |
| Jun 30, 2017 | 1,755.00 |
| Mar 31, 2017 | 1,760.00 |
| Dec 31, 2016 | 1,828.00 |
| Sep 30, 2016 | 2,445.00 |
| Jun 30, 2016 | 4,483.00 |
| Mar 31, 2016 | 1,626.00 |
| Dec 31, 2015 | 1,997.00 |
| Sep 30, 2015 | 1,180.00 |
| Jun 30, 2015 | 1,994.00 |